SK22793A3 - New process for preparimg formoterol and related compounds - Google Patents

New process for preparimg formoterol and related compounds Download PDF

Info

Publication number
SK22793A3
SK22793A3 SK22793A SK22793A SK22793A3 SK 22793 A3 SK22793 A3 SK 22793A3 SK 22793 A SK22793 A SK 22793A SK 22793 A SK22793 A SK 22793A SK 22793 A3 SK22793 A3 SK 22793A3
Authority
SK
Slovakia
Prior art keywords
formula
compound
carbon atoms
straight
branched alkyl
Prior art date
Application number
SK22793A
Other languages
English (en)
Slovak (sk)
Inventor
Jan W Trofast
Edib Jakupovic
Lena K Mansson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SK22793A3 publication Critical patent/SK22793A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/14Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Steroid Compounds (AREA)
SK22793A 1990-09-26 1991-09-25 New process for preparimg formoterol and related compounds SK22793A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9003057A SE9003057D0 (sv) 1990-09-26 1990-09-26 New process
PCT/SE1991/000643 WO1992005147A1 (en) 1990-09-26 1991-09-25 New process for preparing formoterol and related compounds

Publications (1)

Publication Number Publication Date
SK22793A3 true SK22793A3 (en) 1993-07-07

Family

ID=20380456

Family Applications (1)

Application Number Title Priority Date Filing Date
SK22793A SK22793A3 (en) 1990-09-26 1991-09-25 New process for preparimg formoterol and related compounds

Country Status (28)

Country Link
EP (1) EP0550612B1 (pt)
JP (1) JP2801401B2 (pt)
KR (1) KR0179639B1 (pt)
AT (1) ATE134990T1 (pt)
AU (1) AU652386B2 (pt)
BG (1) BG61605B1 (pt)
CA (1) CA2091343C (pt)
CZ (1) CZ284256B6 (pt)
DE (1) DE69117768T2 (pt)
DK (1) DK0550612T3 (pt)
EE (1) EE02979B1 (pt)
ES (1) ES2084831T3 (pt)
FI (1) FI111714B (pt)
GR (1) GR3020134T3 (pt)
HK (1) HK52297A (pt)
HU (1) HU214054B (pt)
IE (1) IE74387B1 (pt)
IS (1) IS1684B (pt)
LT (1) LT3813B (pt)
LV (1) LV10770B (pt)
NO (1) NO301709B1 (pt)
PL (1) PL166434B1 (pt)
PT (1) PT99051B (pt)
RU (1) RU2079486C1 (pt)
SE (1) SE9003057D0 (pt)
SG (1) SG43150A1 (pt)
SK (1) SK22793A3 (pt)
WO (1) WO1992005147A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6299863B1 (en) 1992-04-03 2001-10-09 Sepracor Inc. Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy
US6866839B2 (en) 1991-04-05 2005-03-15 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5629200A (en) * 1993-11-18 1997-05-13 Daicel Chemical Industries, Ltd. Production of optically active 2-amino-1-phenylethanol derivatives by asymetrical assimilation
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
AU722859B2 (en) * 1996-11-11 2000-08-10 Sepracor, Inc. Process for the preparation of optically pure isomers of formoterol
US6040344A (en) 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
US6303145B2 (en) 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
AU2002252950A1 (en) * 2001-02-22 2002-09-04 Universitatsklinikum Charite Medizinische Fakultat Der Humboldt-Universitat Zu Berlin Protein kinase d inhibitors and protein kinase 2 inhibitors as agents for inhibiting tumour cells and for stimulating angiogenesis
US6472563B1 (en) 2001-11-09 2002-10-29 Sepracor Inc. Formoterol tartrate process and polymorph
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
WO2008035380A2 (en) * 2006-09-19 2008-03-27 Natco Pharma Limited An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
JP2011501204A (ja) * 2007-10-29 2011-01-06 ジェネリクス・(ユーケー)・リミテッド 新規なクロマトグラフィー方法
EA017627B1 (ru) 2008-05-13 2013-01-30 Астразенека Аб Хинуклидиновые производные в качестве антагонистов мускаринового м3 рецептора
CN101921200B (zh) * 2009-06-16 2014-01-15 上海医药工业研究院 一种n-苄基-1-(4-甲氧基苯基)-2-丙胺的制备方法
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
CN115368250B (zh) * 2022-09-02 2024-07-26 博诺康源(北京)药业科技有限公司 拆分福莫特罗手性中间体的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2366625C2 (pt) * 1972-02-05 1988-06-09 Yamanouchi Pharmaceutical Co., Ltd., Tokio/Tokyo, Jp
GB1468156A (en) * 1973-07-19 1977-03-23 Ici Ltd Phenylethylamine derivatives
ES2005492A6 (es) 1987-12-23 1989-03-01 Lasa Lab Procedimiento de obtencion de n-(2-hidroxi-5-(1-hidroxi-2((2- (4-metoxifenil)-1metiletil)amino)etil)fenil)foramida (i).

Also Published As

Publication number Publication date
IS1684B (is) 1998-02-24
CA2091343A1 (en) 1992-03-27
NO931058D0 (no) 1993-03-23
FI931333A0 (fi) 1993-03-25
CZ44293A3 (en) 1994-01-19
BG97576A (bg) 1994-03-31
HU9300867D0 (en) 1993-06-28
LT3813B (en) 1996-03-25
WO1992005147A1 (en) 1992-04-02
BG61605B1 (bg) 1998-01-30
IS3756A7 (is) 1992-03-27
GR3020134T3 (en) 1996-08-31
IE913373A1 (en) 1992-04-08
LV10770B (en) 1996-04-20
ATE134990T1 (de) 1996-03-15
ES2084831T3 (es) 1996-05-16
JP2801401B2 (ja) 1998-09-21
AU8652091A (en) 1992-04-15
LTIP1715A (en) 1995-07-25
LV10770A (lv) 1995-08-20
DE69117768T2 (de) 1996-08-29
SG43150A1 (en) 1997-10-17
DE69117768D1 (de) 1996-04-11
PT99051A (pt) 1992-08-31
AU652386B2 (en) 1994-08-25
EE02979B1 (et) 1997-04-15
PL166434B1 (pl) 1995-05-31
FI111714B (fi) 2003-09-15
KR0179639B1 (ko) 1999-05-15
JPH06501262A (ja) 1994-02-10
HK52297A (en) 1997-05-02
IE74387B1 (en) 1997-07-30
EP0550612B1 (en) 1996-03-06
SE9003057D0 (sv) 1990-09-26
HU214054B (en) 1997-12-29
FI931333A (fi) 1993-04-22
CA2091343C (en) 2002-07-09
DK0550612T3 (da) 1996-07-22
RU2079486C1 (ru) 1997-05-20
PT99051B (pt) 1999-02-26
CZ284256B6 (cs) 1998-10-14
EP0550612A1 (en) 1993-07-14
NO301709B1 (no) 1997-12-01
HUT65912A (en) 1994-07-28
NO931058L (no) 1993-03-23

Similar Documents

Publication Publication Date Title
US5434304A (en) Process for preparing formoterol and related compounds
SK22793A3 (en) New process for preparimg formoterol and related compounds
EP1082293B1 (en) Formoterol polymorphs
US5545745A (en) Enantioselective preparation of optically pure albuterol
SK283591B6 (sk) Spôsob prípravy tolterodínu a medziprodukt
Erhardt et al. Ultra-short-acting. beta.-adrenergic receptor blocking agents. 1.(Aryloxy) propanolamines containing esters in the nitrogen substituent
EP0103497B1 (fr) Nouveaux dérivés de la xanthine, leur procédé de préparation et les compositions pharmaceutiques les renfermant
HU215394B (hu) 3-Fenil-izokinolin-1(2H)-on-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
US4336268A (en) Cyclohexene derivative analgesics
JP2758502B2 (ja) (−)−リトドリン
EP0074903B1 (fr) Dérivés d'amino-2 tétrahydro-1,2,3,4 naphtalène, leur préparation et leur application en thérapeutique
FR2643076A1 (fr) Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
RU2086537C1 (ru) S-энантиомер замещенного 2-аминотетралина, способы его получения и фармацевтическая композиция, обладающая свойством антагониста 5-нт*001*00а-рецептора
FR2528422A1 (fr) Nouveaux derives du 1,2,3,4-tetrahydronaphtalene, procede pour leur preparation et composition pharmaceutique contenant ces derives
US4831167A (en) Process for diastereoselective reduction of 3-amino-1-benzoxepin-5(2H)-ones
HU177107B (en) Process for producing new 1-phenyl-ethanolamine derivatives of antyflogistic activity
KR800000537B1 (ko) 아미노-페닐-에탄올아민의 제조방법
CS247575B1 (cs) Deriváty 1-fenoxy-3-fenoxyethylamino-2-propanolu a způsob jejich přípravy
FR2652351A1 (fr) Nouveau derive de l'imidazolepropanamide, sa preparation et son emploi.
HU207308B (en) Process for producing 1- /2-/5-/dimethyl-amino-methyl/-2-/furyl-methyl-thio/-ethyl//- -amino-1-/methyl-amino-2-nitro-ethylene